Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 5.74 AUD -9.89% Market Closed
Updated: May 20, 2024

Mayne Pharma Group Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Cash Paid for Dividends Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Cash Paid for Dividends
-AU$45.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Cash Paid for Dividends
-AU$5.3m
CAGR 3-Years
-16%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-45.3m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Cash Paid for Dividends amounts to -45.3m AUD.